nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Lysine—KARS—oviduct—ovarian cancer	0.112	0.118	CbGeAlD
L-Lysine—SLC7A3—decidua—ovarian cancer	0.0501	0.0527	CbGeAlD
L-Lysine—SLC7A4—female reproductive system—ovarian cancer	0.0366	0.0386	CbGeAlD
L-Lysine—KARS—myometrium—ovarian cancer	0.0359	0.0378	CbGeAlD
L-Lysine—SLC7A3—testis—ovarian cancer	0.0318	0.0335	CbGeAlD
L-Lysine—SLC7A4—testis—ovarian cancer	0.0296	0.0311	CbGeAlD
L-Lysine—SLC7A2—endometrium—ovarian cancer	0.0294	0.0309	CbGeAlD
L-Lysine—KARS—uterine cervix—ovarian cancer	0.0279	0.0294	CbGeAlD
L-Lysine—SLC7A2—gonad—ovarian cancer	0.0273	0.0287	CbGeAlD
L-Lysine—SLC7A2—uterus—ovarian cancer	0.0271	0.0285	CbGeAlD
L-Lysine—KARS—decidua—ovarian cancer	0.0266	0.028	CbGeAlD
L-Lysine—KARS—endometrium—ovarian cancer	0.0253	0.0266	CbGeAlD
L-Lysine—SLC7A2—female reproductive system—ovarian cancer	0.0243	0.0256	CbGeAlD
L-Lysine—SLC7A1—gonad—ovarian cancer	0.024	0.0252	CbGeAlD
L-Lysine—SLC7A1—uterus—ovarian cancer	0.0238	0.0251	CbGeAlD
L-Lysine—KARS—gonad—ovarian cancer	0.0234	0.0247	CbGeAlD
L-Lysine—KARS—uterus—ovarian cancer	0.0233	0.0245	CbGeAlD
L-Lysine—SLC7A2—female gonad—ovarian cancer	0.0222	0.0233	CbGeAlD
L-Lysine—SLC7A2—vagina—ovarian cancer	0.022	0.0232	CbGeAlD
L-Lysine—SLC7A1—female reproductive system—ovarian cancer	0.0214	0.0225	CbGeAlD
L-Lysine—KARS—female reproductive system—ovarian cancer	0.0209	0.022	CbGeAlD
L-Lysine—KARS—bone marrow—ovarian cancer	0.0198	0.0208	CbGeAlD
L-Lysine—SLC7A2—testis—ovarian cancer	0.0197	0.0207	CbGeAlD
L-Lysine—SLC7A1—female gonad—ovarian cancer	0.0195	0.0205	CbGeAlD
L-Lysine—KARS—female gonad—ovarian cancer	0.019	0.02	CbGeAlD
L-Lysine—KARS—vagina—ovarian cancer	0.0189	0.0199	CbGeAlD
L-Lysine—SLC7A1—testis—ovarian cancer	0.0173	0.0182	CbGeAlD
L-Lysine—KARS—testis—ovarian cancer	0.0169	0.0178	CbGeAlD
L-Lysine—SLC7A2—lymph node—ovarian cancer	0.0142	0.015	CbGeAlD
L-Lysine—SLC22A4—myometrium—ovarian cancer	0.014	0.0147	CbGeAlD
L-Lysine—SLC7A1—lymph node—ovarian cancer	0.0125	0.0132	CbGeAlD
L-Lysine—SLC16A10—epithelium—ovarian cancer	0.0123	0.013	CbGeAlD
L-Lysine—KARS—lymph node—ovarian cancer	0.0122	0.0129	CbGeAlD
L-Lysine—SLC22A4—decidua—ovarian cancer	0.0104	0.0109	CbGeAlD
L-Lysine—SLC16A10—gonad—ovarian cancer	0.0103	0.0108	CbGeAlD
L-Lysine—SLC22A4—endometrium—ovarian cancer	0.00986	0.0104	CbGeAlD
L-Lysine—SLC16A10—female reproductive system—ovarian cancer	0.00917	0.00965	CbGeAlD
L-Lysine—SLC16A10—vagina—ovarian cancer	0.00829	0.00872	CbGeAlD
L-Lysine—SLC22A4—female reproductive system—ovarian cancer	0.00816	0.00859	CbGeAlD
L-Lysine—SLC22A4—bone marrow—ovarian cancer	0.00771	0.00811	CbGeAlD
L-Lysine—SLC16A10—testis—ovarian cancer	0.0074	0.00778	CbGeAlD
L-Lysine—SLC22A4—vagina—ovarian cancer	0.00738	0.00777	CbGeAlD
L-Lysine—SLC16A10—lymph node—ovarian cancer	0.00536	0.00564	CbGeAlD
L-Lysine—SLC22A4—lymph node—ovarian cancer	0.00478	0.00503	CbGeAlD
L-Lysine—SLC7A2—Amino acid and oligopeptide SLC transporters—SLC5A5—ovarian cancer	0.00341	0.0686	CbGpPWpGaD
L-Lysine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—ovarian cancer	0.00306	0.0616	CbGpPWpGaD
L-Lysine—SLC7A1—Amino acid and oligopeptide SLC transporters—SLC5A5—ovarian cancer	0.0029	0.0584	CbGpPWpGaD
L-Lysine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	0.00274	0.0552	CbGpPWpGaD
L-Lysine—SLC7A3—Amino acid and oligopeptide SLC transporters—SLC5A5—ovarian cancer	0.0027	0.0543	CbGpPWpGaD
L-Lysine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—ovarian cancer	0.00206	0.0414	CbGpPWpGaD
L-Lysine—SLC7A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.00201	0.0404	CbGpPWpGaD
L-Lysine—SLC7A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.00171	0.0344	CbGpPWpGaD
L-Lysine—SLC7A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.00159	0.0319	CbGpPWpGaD
L-Lysine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC5A5—ovarian cancer	0.00124	0.025	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—WDR77—ovarian cancer	0.00122	0.0245	CbGpPWpGaD
L-Lysine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	0.00107	0.0214	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—TTF1—ovarian cancer	0.000955	0.0192	CbGpPWpGaD
L-Lysine—SLC7A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000903	0.0182	CbGpPWpGaD
L-Lysine—SLC7A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000898	0.0181	CbGpPWpGaD
L-Lysine—SLC7A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000867	0.0174	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—NR5A1—ovarian cancer	0.000867	0.0174	CbGpPWpGaD
L-Lysine—SLC7A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000865	0.0174	CbGpPWpGaD
L-Lysine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	0.000816	0.0164	CbGpPWpGaD
L-Lysine—SLC7A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000767	0.0154	CbGpPWpGaD
L-Lysine—SLC7A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000764	0.0154	CbGpPWpGaD
L-Lysine—SLC7A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000738	0.0148	CbGpPWpGaD
L-Lysine—SLC7A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000736	0.0148	CbGpPWpGaD
L-Lysine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.000732	0.0147	CbGpPWpGaD
L-Lysine—SLC7A3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000713	0.0143	CbGpPWpGaD
L-Lysine—SLC7A3—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.00071	0.0143	CbGpPWpGaD
L-Lysine—SLC7A3—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000686	0.0138	CbGpPWpGaD
L-Lysine—SLC7A3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000684	0.0138	CbGpPWpGaD
L-Lysine—SLC7A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000684	0.0138	CbGpPWpGaD
L-Lysine—SLC7A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000582	0.0117	CbGpPWpGaD
L-Lysine—SLC7A3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000541	0.0109	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—YAP1—ovarian cancer	0.000495	0.00995	CbGpPWpGaD
L-Lysine—SLC7A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000456	0.00918	CbGpPWpGaD
L-Lysine—SLC7A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000441	0.00886	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—PGR—ovarian cancer	0.000432	0.00869	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—PARP1—ovarian cancer	0.000402	0.00807	CbGpPWpGaD
L-Lysine—SLC7A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000388	0.0078	CbGpPWpGaD
L-Lysine—SLC7A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000375	0.00754	CbGpPWpGaD
L-Lysine—SLC7A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000361	0.00726	CbGpPWpGaD
L-Lysine—SLC7A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000348	0.00701	CbGpPWpGaD
L-Lysine—SLC7A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000348	0.007	CbGpPWpGaD
L-Lysine—SLC22A4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000334	0.00672	CbGpPWpGaD
L-Lysine—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000332	0.00668	CbGpPWpGaD
L-Lysine—SLC16A10—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000329	0.00661	CbGpPWpGaD
L-Lysine—SLC16A10—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000327	0.00658	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—PPP2R1A—ovarian cancer	0.000326	0.00655	CbGpPWpGaD
L-Lysine—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000321	0.00646	CbGpPWpGaD
L-Lysine—SLC22A4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00032	0.00644	CbGpPWpGaD
L-Lysine—SLC16A10—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000316	0.00635	CbGpPWpGaD
L-Lysine—SLC16A10—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000315	0.00634	CbGpPWpGaD
L-Lysine—SLC7A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000296	0.00595	CbGpPWpGaD
L-Lysine—SLC7A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000275	0.00553	CbGpPWpGaD
L-Lysine—SLC22A4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000253	0.00509	CbGpPWpGaD
L-Lysine—SLC16A10—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000249	0.00501	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—ESR1—ovarian cancer	0.000231	0.00464	CbGpPWpGaD
L-Lysine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000169	0.0034	CbGpPWpGaD
L-Lysine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000166	0.00334	CbGpPWpGaD
L-Lysine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000163	0.00328	CbGpPWpGaD
L-Lysine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00016	0.00323	CbGpPWpGaD
L-Lysine—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000129	0.00259	CbGpPWpGaD
L-Lysine—SLC16A10—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000127	0.00255	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—MAPK3—ovarian cancer	0.000123	0.00248	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—MYC—ovarian cancer	0.00012	0.00241	CbGpPWpGaD
L-Lysine—KARS—Gene Expression—AKT1—ovarian cancer	8.32e-05	0.00167	CbGpPWpGaD
